News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Thermo Fisher Scientific
(NY:
TMO
)
610.17
-4.37 (-0.71%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Thermo Fisher Scientific
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Here's How Much $100 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth Today
March 14, 2024
Via
Benzinga
3 Nanotechnology Stocks That Could Soar as the Technology Advances
March 14, 2024
A small world with big potential, nanotechnology stocks could soar in the coming years as demand for nanoscale applications grows.
Via
InvestorPlace
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
March 13, 2024
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Thermo Fisher Stock Lights Up The Board, Soars 40% In 5 Months
March 06, 2024
Thermo Fisher stock has risen more than 40% since October. Additionally, it's closed higher nine of the past 11 trading sessions.
Via
Investor's Business Daily
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $15,000 Today
February 06, 2024
Via
Benzinga
Thermo Fisher Scientific: Q4 Earnings Insights
January 31, 2024
Via
Benzinga
A Preview Of Thermo Fisher Scientific's Earnings
January 30, 2024
Via
Benzinga
Samsara, Thermo Fisher Scientific And More: CNBC's 'Final Trades'
March 01, 2024
On CNBC’s "Halftime Report Final Trades," Karen Firestone of Aureus Asset Management said Thermo Fisher Scientific Inc. (NYSE: TMO) is coming back
Via
Benzinga
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink
March 01, 2024
From
Thermo Fisher Scientific Inc.
Via
Business Wire
Thermo Fisher Scientific to Present at TD Cowen 44th Annual Health Care Conference on March 6, 2024
February 28, 2024
From
Thermo Fisher Scientific Inc.
Via
Business Wire
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 5 Years
February 27, 2024
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
Via
Benzinga
Thermo Fisher Scientific Increases Quarterly Dividend
February 21, 2024
From
Thermo Fisher Scientific Inc.
Via
Business Wire
7 Contrarian Biotech Stocks to Consider Amid Sector Weakness
February 15, 2024
Although the healthcare innovation space has struggled recently, these contrarian biotech stocks now offer compelling discounts.
Via
InvestorPlace
Ray Dalio's Bridgewater Makes Waves: Q4 Unveils Strategic Shifts With New Investments, Sector Expansion In Tech
February 15, 2024
Bridgewater Associates, founded by Ray Dalio, made notable changes to its portfolio in Q4 2023. New bets, exits, increased stakes offer insights into its investment strategy.
Via
Benzinga
Buy the Dip: 3 Oversold Stocks Poised for Big Gains
February 15, 2024
Discover how these oversold stocks to buy point towards potential fast gains while their fundamentals support potentially further growth.
Via
InvestorPlace
TransDigm, West Pharmaceutical, Thermo Fisher Scientific And A Tech Company On CNBC's 'Final Trades'
February 08, 2024
On CNBC’s "Halftime Report Final Trades," Steve Weiss of Short Hills Capital Partners named TransDigm Group Incorporated (NYSE: TDG), which is scheduled to release
Via
Benzinga
RBC Capital Maintains Outperform Rating for Thermo Fisher Scientific: Here's What You Need To Know
February 01, 2024
Via
Benzinga
Biotech And Medtech Portfolio Notes On A Fed Day
January 31, 2024
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23%
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
Buy Alert: 3 Stocks Sitting in the Sweet Spot
January 31, 2024
They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting.
Via
InvestorPlace
Nasdaq, S&P 500 Slip Ahead Of Fed Meeting, Regional Banks Sink After NYCB Disappoints: What's Driving Markets Wednesday?
January 31, 2024
Nasdaq down 1.4%, S&P 500 down 0.9%, Dow up: Volatile day on Wall Street as tech stocks react to disappointing earnings ahead of Fed meeting.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Thermo Fisher Scientific (TMO) Q4 2023 Earnings Call Transcript
January 31, 2024
TMO earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook
January 31, 2024
"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance.
Via
Benzinga
Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser
January 31, 2024
The record run of the market faces risk as the big tech earnings season got off to a negative start, casting cloud on profit outlook.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Thermo Fisher Scientific Reports Fourth Quarter and Full Year 2023 Results
January 31, 2024
From
Thermo Fisher Scientific Inc.
Via
Business Wire
Earnings Scheduled For January 31, 2024
January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion.
Via
Benzinga
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
January 30, 2024
EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NYSE:BMY),(NYSE:TMO),(NASDAQ:NTRA),(NASDAQ:NEO) EQNX::TICKER_END
Via
FinancialNewsMedia
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
January 30, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?
January 29, 2024
An analyst sees the Satya Nadella-led company's earnings to be the key barometer for AI spending.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
...
20
21
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.